EFTA00934705Set 9
2012-05-152p629w
From: "Alice Jacobs"
To: "Denise Marston" ctl
Subject: IMDx Obtains CE-marking for GBS Assay for screening for neonatal infections
Date ... hope this message finds you well. I am pleased to inform you that IMDx has obtained CE-marking for a
test for Group B Streptococcus (GBS), the most common pathogen ... improve women's health and prenatal care
Cambridge, MA, May 15, 2012 — IntelligentMDx (IMDx) announced today that it has obtained CE-marking for
a new automated, high-throughput, qualitative
https://www.justice.gov/epstein/files/DataSet%209/EFTA00934705.pdf
EFTA00675936Set 9
2013-11-122p697w
From: Alice Jacobs Nesselrodt :< =>
To: Alice Jacobs Nesselrodt
Subject: IMDx receives 3rd FDA clearance and relocates HQ to Waltham
Date: Tue, 12 Nov 2013 21:14:41 +0000
Attachments: IMDx ... heels of a successful move into our new corporate
headquarters in Waltham, MA, IMDx today announced its third FDA clearance for its C. difficile assay for
Abbott m2000 assay ... best,
Alice
IntelligentMDx Receives FDA Clearance for IMDx C. difficile for Abbott m2000 Assay, Completes Move of
Corporate Headquarters to Waltham
WALTHAM, MA, November 12, 2013 -- IntelligentMDx announced today that
https://www.justice.gov/epstein/files/DataSet%209/EFTA00675936.pdf
EFTA00703494Set 9
2013-07-302p647w
Denise Marston <I
CC: Denise Marston <I
Subject: MDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay
Date: Tue, 30 Jul 2013 14:40:22 +0000
Attachments: IMDx ... doing well and are having a great summer. I am pleased to announce that IMDx has achieved a pivotal
milestone with the receipt of FDA clearance for its Vancomycin Resistance ... wound, urinary tract, and bloodstream infections.
My best,
Alice
IntelligentMDx Receives FDA Clearance for IMDx VanR for Abbott m2000 assay
Cambridge, MA, July 29, 2013 — IntelligentMDx (privately held) announced today
https://www.justice.gov/epstein/files/DataSet%209/EFTA00703494.pdf
EFTA00640072Set 9
2011-01-202p505w
From: "Alice Jacobs"
To: "Alice Jacobs"
Subject: IMDx Enters into Agreement with Abbott
Date: Thu, 20 Jan 2011 22:28:29 +0000
Attachments: IMDx-Abbott Press Release 2011JAN20.pdf
I wanted ... hope that you're doing well.
My best,
Alice
Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu
of Molecular Tests ... Cambridge, MA January 20, 2011— IMDx (privately held) today announced that they have signed a multi-year agreement
with Abbott whereby IMDx will design, develop, regulatory clear, and manufacture assays
https://www.justice.gov/epstein/files/DataSet%209/EFTA00640072.pdf
EFTA00648481Set 9
2011-01-212p669w
From: "Alice Jacobs" •
To: "Jeffrey Epstein" <jeevacation@gmail.com>
Subject: RE: IMDx Enters into Agreement with Abbott
Date: Fri, 21 Jan 2011 13:31:06 +0000
From you—that means ... jeevacation@gmail.com]
Sent: Friday, January 21, 2011 7:00 AM
To: Alice Jacobs
Subject: Re: IMDx Enters into Agreement with Abbott
great .. im proud ... hope that you're doing well.
My best,
Alice
Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu
of Molecular Tests
https://www.justice.gov/epstein/files/DataSet%209/EFTA00648481.pdf
EFTA00924754Set 9
2011-11-303p932w
Hawwa
Cc: Denise Marston
Cambridge, MA - November, 2011- Dr. Alice Jacobs, CEO of IntelligentMDx (IMDx),was named Best
Entrepreneur for a non-service business of up to 100 employees ... Jacobs' entrepreneurial spirit has fueled her passion for finding innovative solutions in healthcare. IMDx
was founded out of what she believed was an underserved need in the industry: rapid ... goal of empowering
physicians to make early, intelligent choices regarding patient treatment.
In 2011, IMDx has doubled in size, creating high technology jobs for top talent in the intellectual property
https://www.justice.gov/epstein/files/DataSet%209/EFTA00924754.pdf
EFTA00906003Set 9
2011-03-162p578w
From: "Alice Jacobs" •
To: "Denise Marston" <
Subject: IMDx Enters into Agreement with Biosearch
Date: Wed, 16 Mar 2011 13:05:51 +0000
Attachments: -15MAR2011.pdf
I wanted to update ... with more news from IMDx.
I hope that 2011 continues to be a great year for all of us.
My best,
Alice
Biosearch Technologies and Intelligent Medical Devices, Inc. (IMDx ... leading
supplier of sophisticated oligonucleotide components to the rapidly growing molecular diagnostics industry, and IMDx
(privately held), a developer and manufacturer of innovative, clinically impactful molecular test solutions, today announced
https://www.justice.gov/epstein/files/DataSet%209/EFTA00906003.pdf
EFTA00902109Set 9
2011-01-213p622w
From: Jeffrey Epstein <jeevacation@gmail.com>
To: Alice Jacobs
Subject: Re: IMDx Enters into Agreement with Abbott
Date: Fri, 21 Jan 2011 12:00:02 +0000
great .. im proud ... hope that you're doing well.
My best,
Alice
Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad
Menu of Molecular Tests ... Cambridge, MA January 20, 2011— IMDx (privately held) today announced that they have signed a multi-year
agreement with Abbott whereby IMDx will design, develop, regulatory clear, and manufacture assays
https://www.justice.gov/epstein/files/DataSet%209/EFTA00902109.pdf
EFTA00687759Set 9
2011-08-022p479w
From: "Alice Jacobs"
To: "Denise Marston"
Subject: IMDx Introduces CE-marked Assay for C. difficile for European Market
Date: Tue, 02 Aug 2011 23:45:37 +0000
I wanted ... hope that you're doing well.
My best,
Alice
Intelligent Medical Devices, Inc. (IMDx) Introduces a CE-Marked Automated Assay
for the Detection of C. difficile Including Hypervirulent Strains
CAMBRIDGE ... Mass., Aug. 1, 2011 /PRNewswire/ -- Intelligent Medical Devices, Inc. (IMDx) today
announced it has received CE-Mark for a high-throughput automated assay for the detection of C.
difficile, including
https://www.justice.gov/epstein/files/DataSet%209/EFTA00687759.pdf
EFTA00719780Set 9
2011-11-292p812w
Cambridge, MA - November, 2011- Dr. Alice Jacobs, CEO of IntelligentMDx (IMDx),was named Best
Entrepreneur for a non-service business of up to 100 employees in the eighth annual Stevie ... Jacobs' entrepreneurial spirit has fueled her passion for finding innovative solutions in healthcare. IMDx
was founded out of what she believed was an underserved need in the industry: rapid ... goal of empowering
physicians to make early, intelligent choices regarding patient treatment.
In 2011, IMDx has doubled in size, creating high technology jobs for top talent in the intellectual property
https://www.justice.gov/epstein/files/DataSet%209/EFTA00719780.pdf
EFTA00930939Set 9
2012-03-133p654w
Marston
Cambridge, MA, March 6, 2012 — Dr. Alice Jacobs, Chairman and CEO of IntelligentMDx (IMDx), has been
named a 2012 Woman to Watch by Mass High Tech. This ... receive this distinction along with other great women."
Under the leadership of Dr. Jacobs, IMDx designs, develops, and manufactures clinically relevant molecular
diagnostics for rapid and accurate detection of diseases ... IMDx released two CE-marked diagnostic kits,
which are being distributed globally by Abbott, targeting two of the most threatening healthcare-associated
infections, Clostridium dinette, and vancomycin-resistant enterococci. Diagnostic
https://www.justice.gov/epstein/files/DataSet%209/EFTA00930939.pdf
EFTA00718974Set 9
2012-03-132p705w
Marston <
Cambridge, MA, March 6, 2012 — Dr. Alice Jacobs, Chairman and CEO of IntelligentMDx (IMDx), has been
named a 2012 Woman to Watch by Mass High Tech. This ... receive this distinction along with other great women."
Under the leadership of Dr. Jacobs, IMDx designs, develops, and manufactures clinically relevant molecular
diagnostics for rapid and accurate detection of diseases ... IMDx released two CE-marked diagnostic kits,
which are being distributed globally by Abbott, targeting two of the most threatening healthcare-associated
infections, Clostridium dinette, and vancomycin-resistant enterococci. Diagnostic
https://www.justice.gov/epstein/files/DataSet%209/EFTA00718974.pdf
EFTA00614609Set 9
2011-01-201p379w
Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the
Distribution of a Broad Menu of Molecular Tests
Cambridge, MA January 20, 2011— IMDx (privately held) today ... announced that they have
signed a multi-year agreement with Abbott whereby IMDx will design, develop, regulatory clear,
and manufacture assays for the Abbott Molecular FDA cleared, m2000 instrument system ... distributed worldwide. Financial terms have not been disclosed.
IMDx tests are state of the art incorporating important and evolving clinical needs. The tests are
designed utilizing IMDx's proprietary bioinformatics
https://www.justice.gov/epstein/files/DataSet%209/EFTA00614609.pdf